Form 4 Filing for RONNEBERG AMY L

Amy L. Ronneberg, a director at Actuate Therapeutics, Inc., acquired 15,000 stock options on May 21, 2026. These options, granted under the company's equity incentive plan, have an exercise price of $2.42 per share and an expiration date of May 21, 2036. The options will vest in full on the anniversary of the grant date. This transaction, reported on Form 4, indicates a change in the reporting owner's beneficial ownership of securities. The underlying security for these options is the company's Common Stock.